These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15839718)

  • 1. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines.
    Hansen J; Klimek L; Hörmann K
    Drugs Aging; 2005; 22(4):289-96. PubMed ID: 15839718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H1-antihistamines in the elderly.
    Kaliner MA
    Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihistamines in late-phase clinical development for allergic disease.
    Salmun LM
    Expert Opin Investig Drugs; 2002 Feb; 11(2):259-73. PubMed ID: 11829715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of histamine H1-receptor antagonist drugs.
    Du Buske LM
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S307-18. PubMed ID: 8977542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.
    Corey JP
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
    Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA
    Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the drug management of allergic rhinitis.
    Mygind N
    Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S68-72. PubMed ID: 7734978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL; Goa KL
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and topical antihistamines: pharmacologic properties and therapeutic potential in ocular allergic disease.
    Jaanus SD
    J Am Optom Assoc; 1998 Feb; 69(2):77-87. PubMed ID: 9549258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of H1-antihistamines: an update.
    Kalpaklioglu F; Baccioglu A
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):230-7. PubMed ID: 23173575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H1-antihistamines in children.
    Simons FE
    Clin Allergy Immunol; 2002; 17():437-64. PubMed ID: 12113226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contemporary opinions on the use of new generation H1 receptor blockers for allergies].
    Wrzyszcz M; Makuch B
    Pneumonol Alergol Pol; 1997; 65 Suppl 1():84-8. PubMed ID: 9410308
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new generation of antihistaminics (H1)].
    Tarchalska B; Zawisza E
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1672-5. PubMed ID: 2908342
    [No Abstract]   [Full Text] [Related]  

  • 20. H1-receptor antagonists: does a dose-response relationship exist?
    Simons FE
    Ann Allergy; 1993 Dec; 71(6):592-7. PubMed ID: 7903516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.